Metallo-β-lactamases in the age of multidrug resistance: from structure and mechanism to evolution, dissemination, and inhibitor design

G Bahr, LJ Gonzalez, AJ Vila - Chemical Reviews, 2021 - ACS Publications
Antimicrobial resistance is one of the major problems in current practical medicine. The
spread of genes coding for resistance determinants among bacteria challenges the use of …

Antibiotic adjuvants: A versatile approach to combat antibiotic resistance

G Dhanda, Y Acharya, J Haldar - ACS omega, 2023 - ACS Publications
The problem of antibiotic resistance is on the rise, with multidrug-resistant strains emerging
even to the last resort antibiotics. The drug discovery process is often stalled by stringent cut …

β-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs

C Gonzalez-Bello, D Rodríguez, M Pernas… - Journal of medicinal …, 2019 - ACS Publications
Infections caused by resistant bacteria are nowadays too common, and some pathogens
have even become resistant to multiple types of antibiotics, in which case few or even no …

B1-metallo-β-lactamases: where do we stand?

MF Mojica, RA Bonomo, W Fast - Current drug targets, 2016 - ingentaconnect.com
Metallo-β-Lactamases (MBLs) are class B β-lactamases that hydrolyze almost all clinically-
available β-lactam antibiotics. MBLs feature the distinctive αβ/βα sandwich fold of the …

New Delhi metallo-β-lactamase: structural insights into β-lactam recognition and inhibition

DT King, LJ Worrall, R Gruninger… - Journal of the American …, 2012 - ACS Publications
The β-lactam antibiotics have long been a cornerstone for the treatment of bacterial disease.
Recently, a readily transferable antibiotic resistance factor called the New Delhi metallo-β …

Ten years with New Delhi metallo-β-lactamase-1 (NDM-1): from structural insights to inhibitor design

P Linciano, L Cendron, E Gianquinto… - ACS infectious …, 2018 - ACS Publications
The worldwide emergence of New Delhi metallo-β-lactamase-1 (NDM-1) as a
carbapenemase able to hydrolyze nearly all available β-lactam antibiotics has characterized …

β-lactam antibiotics and β-lactamase enzymes inhibitors, part 2: our limited resources

S Alfei, AM Schito - Pharmaceuticals, 2022 - mdpi.com
β-lactam antibiotics (BLAs) are crucial molecules among antibacterial drugs, but the
increasing emergence of resistance to them, developed by bacteria producing β-lactamase …

Structural basis of metallo-β-lactamase inhibition by captopril stereoisomers

J Brem, SS van Berkel, D Zollman, SY Lee… - Antimicrobial agents …, 2016 - Am Soc Microbiol
ABSTRACT β-Lactams are the most successful antibacterials, but their effectiveness is
threatened by resistance, most importantly by production of serine-and metallo-β …

Metallo-ß-lactamases: a review

P Behzadi, HA García-Perdomo, TM Karpiński… - Molecular Biology …, 2020 - Springer
Microbial pathogens including Enterobacteriaceae family members bear different antibiotic
resistance genes comprising Extended-Spectrum-ß-Lactamases (ESBLs) and Metallo-ß …

Dipicolinic acid derivatives as inhibitors of New Delhi metallo-β-lactamase-1

AY Chen, PW Thomas, AC Stewart… - Journal of medicinal …, 2017 - ACS Publications
The efficacy of β-lactam antibiotics is threatened by the emergence and global spread of
metallo-β-lactamase (MBL) mediated resistance, specifically New Delhi metallo-β-lactamase …